RMA of New York to Present 22 Studies at ASRM 2026

RMA of New York will present 22 research abstracts and collect two ASRM awards at the 2026 Scientific Congress & Expo in Baltimore. The studies focus on reproductive aging, ovarian reserve, embryo development and changing family-building arrangements.

Why it matters: - RMA of New York’s ASRM showing puts patient care questions, fertility counseling and embryo selection research in front of the field’s largest professional audience. - The work could influence how clinicians discuss ovarian reserve, interpret embryo potential and navigate evolving family-building arrangements. - Two ASRM awards also underscore the group’s research profile inside reproductive medicine.

What happened: - RMA of New York will present 22 accepted abstracts at the 2026 American Society for Reproductive Medicine Scientific Congress & Expo in Baltimore. - Dr. Emily Clarke will receive the 2026 ASRM New Investigator Award for her manuscript, Frozen Embryo Transfer Outcomes in Patients with Prior Cesarean Delivery: A Focus on Endometrial Lining Parameters. - Dr. Jensen Reckhow will receive the 2026 ASRM In Training Award for Research for the abstract, Live Birth After Day 7 Frozen Embryo Transfer Is Associated with Prior Transfer History, Not Cohort Composition. - The abstracts come from the collaboration between RMA of New York and the Icahn School of Medicine at Mount Sinai.

The details: - The accepted work spans reproductive aging, ovarian reserve, embryology and family building. - One study led by second-year fellow Dr. Rebecca Zhou established age-specific anti-Müllerian hormone reference values in 6,413 infertile women ages 21-48. - The AMH levels were higher across age groups than previously published general-population values. - The pattern of age-related decline changed after age 35. - The study did not show faster ovarian reserve depletion in infertile women compared with population data. - Another study looked at counseling on age-related fertility decline. - Researchers interviewed 27 experts across reproductive endocrinology, OB/GYN, primary care, maternal-fetal medicine, family planning and women’s health advocacy. - The study points to routine, fact-based counseling on reproductive aging. - The findings suggest general OB/GYNs and primary care physicians are well positioned to start those conversations. - Dr. Michelle Bayefsky led that study and said counseling should be normalized and offered regardless of parity or reproductive history. - Dr. Miriam Andrusier studied abnormally fertilized zygotes using outcomes from 161,911 mature oocytes across 9,535 patients. - The study found that some zygotes with non-standard pronuclear numbers can form euploid blastocysts. - Cleavage, blastulation and euploidy rates varied by pronuclear number. - The findings add to evidence on embryos that might otherwise be excluded from consideration. - A mixed-methods study led by Dr. Bayefsky examined gestational carrier agreements in New York and California through interviews with 31 reproductive attorneys. - The study found increases in gestational carrier compensation over the past five years. - The study also found evolving provisions tied to travel, health behaviors and other parts of gestational carrier arrangements. - Differences between New York and California reflected different legal and regulatory environments. - Alan Copperman, MD, said the work reflects ASRM’s theme of Discovery, Innovation, and Advancement. - Copperman is director of the Division of Reproductive Endocrinology and Infertility at the Icahn School of Medicine at Mount Sinai and CEO of RMA of New York. - Erkan Buyuk, MD, said the breadth and quality of the research reflects the academic rigor and curiosity of the fellowship and broader academic program. - Buyuk is fellowship director.

Between the lines: - The research mix shows RMA of New York is not limiting itself to lab outcomes; it is also studying counseling, legal structures and clinical decision-making. - Several projects focus on questions that affect what patients hear, what embryos are considered and how fertility care adapts to changing social and legal norms. - The awards and abstract volume suggest the Mount Sinai-linked program is trying to pair high-volume clinical data with academic publication and trainee development.

What's next: - The abstracts will be presented at the ASRM Scientific Congress & Expo in Baltimore. - The studies may inform future counseling practices, embryo assessment approaches and discussions around gestational carrier agreements. - RMA of New York said the broader goal is to translate research into more precise and effective fertility care.

The bottom line: - RMA of New York is using ASRM 2026 to showcase a wide research portfolio that blends clinical data, trainee-led science and real-world fertility policy questions.